EUREKA Italy - Evaluation of Real-life Use of KLOX BioPhotonic System in Chronic Wounds Management

Launched by KLOX TECHNOLOGIES INC. · Jan 13, 2017

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Signed and dated written informed consent form;
• • Adult patient (at least 18 years old) having received a diagnosis of venous leg ulcer, diabetic foot ulcer or pressure ulcer by the Investigator;
• • The treating physician (investigator) believes the KLOX LumiHeal BioPhotonic System would be an appropriate option;
• • Both male and female patients must be willing to adhere to a medically-accepted birth control method during the course of the study;
• • Willingness to comply with study requirements (visits, treatments, etc.).
• Exclusion Criteria:
• • Female pregnant patient (by medical history or as ascertained by a pregnancy test);
• • Breast-feeding female patient;
• • Patients taking drugs/products (e.g., methotrexate, chemotherapy agents) or with conditions (e.g., porphyria) known to induce severe photosensitivity reactions;
• • Patients with known skin hypersensitivity.